|
80
|
269
|
3srvB |
Crystal structure of spleen tyrosine kinase (syk) in complex with a diaminopyrimidine carboxamide inhibitor |
|
75
|
276
|
3skcA |
Human b-raf kinase in complex with an amide linked pyrazolopyridine inhibitor |
|
99
|
307
|
3socA |
Crystal structure of activin receptor type-iia (acvr2a) kinase domain in complex with a quinazolin |
|
103
|
298
|
3sg8A |
Crystal structure of aminoglycoside-2''-phosphotransferase type iva tobramycin complex |
|
91
|
304
|
3slsA |
Crystal structure of human mek-1 kinase in complex with ucb1353770 and amppnp |
|
124
|
438
|
3soaA |
Full-length human camkii |
|
88
|
316
|
3sheA |
Novel atp-competitive mk2 inhibitors with potent biochemical and cell-based activity throughout the series |
|
107
|
350
|
3sd0A |
Identification of a glycogen synthase kinase-3b inhibitor that attenuates hyperactivity in clock mutant mice |
|
95
|
296
|
3sgcA |
Crystal structure of apo aminoglycoside-2''-phosphotransferase type iva |
|
96
|
418
|
3sdjA |
Structure of rnase-inactive point mutant of oligomeric kinase/rnase ire1 |
|
100
|
297
|
3sg9A |
Crystal structure of aminoglycoside-2''-phosphotransferase type iva kanamycin a complex |
|
77
|
287
|
3sc1A |
Novel isoquinolone pdk1 inhibitors discovered through fragment-based lead discovery |
|
104
|
350
|
3sayA |
Crystal structure of human glycogen synthase kinase 3 beta (gsk3b) in complex with inhibitor 142 |
|
94
|
310
|
3s95A |
Crystal structure of the human limk1 kinase domain in complex with staurosporine |
|
80
|
298
|
3rzbA |
Cdk2 in complex with inhibitor rc-2-23 |
|
75
|
298
|
3s2pA |
Crystal structure of cdk2 with a 2-aminopyrimidine compound |
|
104
|
349
|
3s3iA |
P38 kinase crystal structure in complex with small molecule inhibitor |
|
88
|
292
|
3rvgA |
Crystals structure of jak2 with a 1-amino-5h-pyrido[4,3-b]indol-4-carboxamide inhibitor |
|
82
|
287
|
3rwpA |
Discovery of a novel, potent and selective inhibitor of 3-phosphoinositide dependent kinase (pdk1) |
|
96
|
355
|
3rtpA |
Design and synthesis of brain penetrant selective jnk inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration |
|
85
|
349
|
3s4qA |
P38 alpha kinase complexed with a pyrazolo-triazine based inhibitor |
|
84
|
288
|
3rwqA |
Discovery of a novel, potent and selective inhibitor of 3-phosphoinositide dependent kinase (pdk1) |
|
85
|
298
|
3royA |
Cdk2 in complex with inhibitor kvr-1-154 |
|
83
|
298
|
3rm6A |
Cdk2 in complex with inhibitor kvr-2-80 |
|
86
|
298
|
3rprA |
Cdk2 in complex with inhibitor rc-2-49 |
|
110
|
348
|
3rocA |
Crystal structure of human p38 alpha complexed with a pyrimidinone compound |
|
82
|
298
|
3rpvA |
Cdk2 in complex with inhibitor rc-2-88 |
|
104
|
334
|
3rpsA |
Structure of human ck2alpha in complex with the atp-competitive inhibitor 3-(4,5,6,7-tetrabromo-1h-benzotriazol-1-yl)propan-1-ol |
|
79
|
298
|
3rmfA |
Cdk2 in complex with inhibitor rc-2-33 |
|
77
|
290
|
3rnyA |
Crystal structure of human rsk1 c-terminal kinase domain |
|
79
|
298
|
3rpyA |
Cdk2 in complex with inhibitor rc-2-40 |
|
117
|
406
|
3rp9A |
Crystal structure of the apo mapk from toxoplasma gondii, 25.m01780 or tgme49_007820 |
|
83
|
298
|
3rm7A |
Cdk2 in complex with inhibitor kvr-1-91 |
|
79
|
298
|
3rniA |
Cdk2 in complex with inhibitor rc-3-86 |
|
83
|
298
|
3rpoA |
Cdk2 in complex with inhibitor kvr-1-156 |
|
77
|
298
|
3r8lA |
Cdk2 in complex with inhibitor l3-4 |
|
79
|
298
|
3rjcA |
Cdk2 in complex with inhibitor l4-12 |
|
94
|
355
|
3rgfA |
Crystal structure of human cdk8/cycc |
|
82
|
298
|
3rahA |
Cdk2 in complex with inhibitor rc-2-22 |
|
79
|
298
|
3ralA |
Cdk2 in complex with inhibitor rc-2-34 |
|
79
|
298
|
3r7uA |
Cdk2 in complex with inhibitor kvr-1-75 |
|
79
|
298
|
3r8mA |
Cdk2 in complex with inhibitor l3-3 |
|
78
|
298
|
3rkbA |
Cdk2 in complex with inhibitor rc-2-73 |
|
83
|
298
|
3r83A |
Cdk2 in complex with inhibitor kvr-2-92 |
|
78
|
298
|
3r9hA |
Cdk2 in complex with inhibitor rc-2-142 |
|
79
|
298
|
3r7iA |
Cdk2 in complex with inhibitor kvr-1-74 |
|
82
|
298
|
3r9oA |
Cdk2 in complex with inhibitor rc-2-143 |
|
77
|
298
|
3rk5A |
Cdk2 in complex with inhibitor rc-2-72 |
|
114
|
351
|
3rawA |
Crystal structure of human cdc-like kinase 3 isoform in complex with leucettine l41 |
|
79
|
298
|
3r8uA |
Cdk2 in complex with inhibitor rc-1-132 |
